The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2023
Filed:
Jan. 10, 2022
Applicant:
Reneo Pharmaceuticals, Inc., Irvine, CA (US);
Inventors:
Susana Del Rio Gancedo, Cambridge, GB;
Osama Suleiman, Cambridge, GB;
Emma Sharp, Cambridge, GB;
Cristina Balogh, Cambridge, GB;
Rachael Lee, Billingham, GB;
Julie Macrae, Sandwich, GB;
Neil Feeder, Sandwich, GB;
Assignee:
RENEO PHARMACEUTICALS, INC., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); C07D 295/096 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
C07D 295/096 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 9/2054 (2013.01); A61K 9/4825 (2013.01); A61K 9/4866 (2013.01); C07B 2200/13 (2013.01);
Abstract
Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPARδ agonist compound.